PAPER Lojkowska W, Witkowski G, Bednarska-Makaruk M, Wehr H, Sienkiewicz-Jarosz H, Graban A, Bochynska A, Wisniewska A, Gugala M, Slawinska K, Sawicka B, Poniatowska R, Ryglewicz D
SEARCH RESULTS
330913 RESULTS
PAPER Khan A, Yavorsky C, Diclemente G, Opler M, Liechti S, Rothman B, Jovic S
Reliability of the Alzheimer's Disease Assessment Scale (ADAS-Cog) in longitudinal Studies.
Curr Alzheimer Res. 2013 Nov;10(9):952-63. PubMed: 24117118PAPER Frost S, Kanagasingam Y, Sohrabi H, Bourgeat P, Villemagne V, Rowe CC, Macaulay SL, Szoeke C, Ellis KA, Ames D, Masters CL, Rainey-Smith S, Martins RN, AIBL Research Group
Pupil response biomarkers for early detection and monitoring of Alzheimer's disease.
Curr Alzheimer Res. 2013 Nov;10(9):931-9. PubMed: 24117119PAPER He J, Qiao JP, Zhu S, Xue M, Chen W, Wang X, Tempier A, Huang Q, Kong J, Li XM
Serum β-Amyloid Peptide Levels Spike in the Early Stage of Alzheimer- Like Plaque Pathology in an APP/PS1 Double Transgenic Mouse Model.
Curr Alzheimer Res. 2013 Nov;10(9):979-86. PubMed: 24117120PAPER Despa F, Decarli C
Amylin: what might be its role in Alzheimer's disease and how could this affect therapy?
Expert Rev Proteomics. 2013 Oct;10(5):403-5. PubMed: 24117198PAPER Kosaraju J, Murthy V, Khatwal RB, Dubala A, Chinni S, Muthureddy Nataraj SK, Basavan D
Vildagliptin: an anti-diabetes agent ameliorates cognitive deficits and pathology observed in streptozotocin-induced Alzheimer's disease.
J Pharm Pharmacol. 2013 Dec;65(12):1773-84. PubMed: 24117480PAPER Parekh KD, Dash RP, Pandya AN, Vasu KK, Nivsarkar M
Implication of novel bis-imidazopyridines for management of Alzheimer's disease and establishment of its role on protein phosphatase 2A activity in brain.
J Pharm Pharmacol. 2013 Dec;65(12):1785-95. PubMed: 24117507PAPER Lant SB, Robinson AC, Thompson JC, Rollinson S, Pickering-Brown S, Snowden JS, Davidson YS, Gerhard A, Mann DM
Patterns of microglial cell activation in frontotemporal lobar degeneration.
Neuropathol Appl Neurobiol. 2014 Oct;40(6):686-96. PubMed: 24117616PAPER Liu S, Breitbart A, Sun Y, Mehta PD, Boutajangout A, Scholtzova H, Wisniewski T
Blocking the Apolipoprotein E/Amyloid β Interaction in Triple Transgenic Mice Ameliorates Alzheimer's Disease Related Amyloid β and Tau Pathology.
J Neurochem. 2013 Oct 10; PubMed: 24117759PAPER Suárez-Calvet M, Belbin O, Pera M, Badiola N, Magrané J, Guardia-Laguarta C, Muñoz L, Colom M, Clarimón J, Lleó A
Autosomal-dominant Alzheimer's disease mutations at the same codon of Amyloid Precursor Protein differentially alter Aβ production.
J Neurochem. 2013 Oct 11; PubMed: 24117942PAPER Zhan XQ, Yao JJ, Liu DD, Ma Q, Mei YA
Aβ40 modulates GABAA receptor α6 subunit expression and rat cerebellar granule neuron maturation through the ERK/mTOR pathway.
J Neurochem. 2013 Oct 1; PubMed: 24118019PAPER Tian T, Zhang B, Jia Y, Li Z
Can the lens model provide a biomarker for Alzheimer's disease?
Brain Pathol. 2013 Nov;23(6):696. PubMed: 24118485PAPER Pereira JB, Cavallin L, Spulber G, Aguilar C, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Spenger C, Aarsland D, Lovestone S, Simmons A, Wahlund LO, Westman E,
Influence of age, disease onset and ApoE4 on visual medial temporal lobe atrophy cut-offs.
J Intern Med. 2013 Oct 11; PubMed: 24118559PAPER Quintas JL, Souza VC, Henriques AD, Machado-Silva W, Toledo JO, Córdova C, Moraes CF, Camargos EF, Nóbrega OT
Lack of association between apolipoprotein E genotypes and cognitive performance in the non-demented elderly.
Psychogeriatrics. 2013 Oct 7; PubMed: 24118648PAPER Kwak YT, Yang Y, Pyo SJ, Koo MS
Clinical characteristics according to depression screening tools in patients with Alzheimer's disease: View from self, caregiver-reported and drug-intervention pattern.
Geriatr Gerontol Int. 2013 Sep 30; PubMed: 24118908Current Filters
No filters selected